We characterize the activity of fluorofolin, a potent inhibitor of dihydrofolate reductase, against Pseudomonas aeruginosa. By exploiting a divergence in thymidine metabolism, fluorofolin becomes selective for P. aeruginosa in the presence of thymine, demonstrating that it can be a narrow-spectrum antibiotic for this bacterial pathogen.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Murray, C. J. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022). This paper reports on the global public-health burden of antimicrobial resistance, including deaths attributable to and associated with antibiotic-resistant P. aeruginosa infection.
Reynolds, D. & Kollef, M. The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update. Drugs 81, 2117–2131 (2021). A review presenting information on the treatment of P. aeruginosa multidrug-resistant infections.
Melander, R. J., Zurawski, D. V. & Melander, C. Narrow-spectrum antibacterial agents. MedChemComm 9, 12–21 (2018). A review discussing the benefits of narrow-spectrum antibiotics, including some information on the importance of microbiota integrity.
Sandrini, M. P. B., Clausen, A. R., Munch-Petersen, B. & Piškur, J. Thymidine kinase diversity in bacteria. Nucleosides Nucleotides Nucleic Acids 25, 1153–1158 (2006). This paper reports on the diversity in thymidine kinases across different species of bacteria.
Martin, J. K. II et al. A dual-mechanism antibiotic kills Gram-negative bacteria and avoids drug resistance. Cell 181, 1518–1532.e14 (2020). This paper reports on the Irresistin class of antimicrobials from which fluorofolin was derived.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Chain, C. et al. A folate inhibitor exploits metabolic differences in Pseudomonas aeruginosa for narrow-spectrum targeting. Nat. Microbiol. https://doi.org/10.1038/s41564-024-01665-2 (2024).
Rights and permissions
About this article
Cite this article
Narrow-spectrum antibiotic exploits metabolic differences to inhibit Pseudomonas aeruginosa. Nat Microbiol (2024). https://doi.org/10.1038/s41564-024-01673-2
Published:
DOI: https://doi.org/10.1038/s41564-024-01673-2
